Yazar "Karacaer, Zehra" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Assessment of health related quality of life in chronic hepatitis B infection patients in Turkey: a multicenter study
    (Elsevier Science Bv, 2016) Karacaer, Zehra; Çakır, Banu; Erdem, Hakan; Uğurlu, Kenan; Durmuş, Gül; Sırmatel, Fatma
    Quality of Life (HBQOL) questionnaire form. Because five-factor structure for the HBQOL fitted well into Turkish data in publised study, Transmissibility subscale was not analyzed. The data analyzed via SPSS v.22.0 (SPSS Inc., Chicago, IL, USA). The factors related to HRQOL were determined. p < 0.05 was considered significant. Results: A total of 4257 patients (1529 patients in group 1, 1721 patients in group 2, 1007 patients in group 3) were studied. The study group included 2559 (60.1%) male and 1698 (%39.9) female with a median age of 40 years (min-max: 18–84 years). The median ALT levels was 25 U/L (min-max: 0–961 U/L), and the median HBV DNA levels was 76 IU/mL (0–19 × 109 IU/mL). 3657 (85.9%) cases were HbeAg negative. There were statistically significant differences among the study groups according to SF-36 physical component scores, mental component scores and HBQOL total scores (respectively p = <0.001, p = <0.001, p = <0.001). The statistically significant differences were found between SF-36 physical component scores and education level ( p = 0.028), undergoing antiviral treatment ( p = <0.001), ALT levels ( p = 0.004); also SF-36 mental component scores and undergoing antiviral treatment ( p = 0.012), ALT levels ( p = 0.038). Statistically significant differences were noted regarding HBQOL total scores and gender ( p = 0.001), marriage status ( p = 0.002), undergoing antiviral treatment ( p = 0.011), other chronic disease status ( p = <0.001), hospital type ( p = <0.001), HBeAg status ( p = <0.001), ALT levels ( p = 0.001). When all these factors were controlled simultaneously, the scores were higher significantly in inactive CHB patients.
  • Küçük Resim
    Öğe
    Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey
    (Bmc, 2016) Karacaer, Zehra; Çakır, Banu; Erdem, Hakan; Uğurlu, Kenan; Durmuş, Gül; İnce, Nevin Koç; Öztürk, Çınar; Sırmatel, Fatma
    Background: The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. Methods: This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. Results: Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. Conclusions: The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.